FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to an agent for treating a malignant pancreatic tumor. Disclosed is the use of an extract of algal proteoglycan or a composition comprising an extract of algal proteoglycan, in the manufacture of a medicament for the treatment of a malignant pancreatic tumor, wherein the algal proteoglycan extract is obtained using certain steps. Disclosed is a method of treating a malignant pancreatic tumor in a subject, comprising administering to a subject an effective therapeutic amount of an algal proteoglycan extract or a composition comprising an algal proteoglycan extract. What is presented is using a pharmaceutical composition containing an algal proteoglycan extract and one or more other antitumour agents in the manufacture of a medicament for the treatment of a malignant pancreatic tumor. Disclosed is a method of treating a malignant pancreatic tumor in a subject, comprising administering to a subject an effective therapeutic amount of a pharmaceutical composition, containing extract of algal proteoglycan and one or several other anticancer agents.
EFFECT: above-described extract or composition containing it are effective for treating pancreatic malignant tumor.
14 cl, 3 dwg, 20 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL ANTITUMOR COMPOUNDS | 2003 |
|
RU2356908C2 |
COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID | 2011 |
|
RU2605335C2 |
TREATING CANCER WITH COMBINATION OF RADIATION THERAPY, CERIUM OXIDE NANOPARTICLES AND CHEMOTHERAPEUTIC AGENT | 2015 |
|
RU2704811C2 |
COMBINATION THERAPY | 2013 |
|
RU2677245C2 |
ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX | 2017 |
|
RU2742726C2 |
DIAGNOSTICS AND TREATMENT OF MALIGNANT TUMOURS OF PANCREAS, OVARIES AND OTHER MALIGNANT TUMOURS | 2009 |
|
RU2556129C2 |
PHARMACEUTICAL COMBINATION CONTAINING TNO155 AND RIBOCICLIB | 2020 |
|
RU2813111C2 |
METHOD FOR DETERMINING PROBABILITY OF THERAPEUTIC RESPONSE ON CANCER THERAPY WITH CARDIAC GLYCOSIDE | 2008 |
|
RU2508114C2 |
KIT FOR DETECTING PROBABILITY OF THERAPEUTIC RESPONSE TO ANTI-CANCER CHEMOTHERAPY WITH CARDIAC GLYCOSIDE | 2008 |
|
RU2571687C2 |
METHOD FOR THERAPY OF MALIGNANT TUMOUR | 2011 |
|
RU2577993C2 |
Authors
Dates
2020-12-25—Published
2017-01-20—Filed